Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: A combined Danish and Swedish study

Clinical and Experimental Immunology

Volumn 130, Issue 3, 2002, Pages 495-500

  Mellemkjær, Lene ^a   Hammarstrom L ^b   Andersen, V ^c   Yuen, J ^d   Heilmann, C ^c   Barington, T ^c,e   Bjorkander J ^f   Olsen, J H ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Rigshospitalet   (Denmark)

^d SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer risk; Common variable immunodeficiency; Epidemiology; IgA deficiency; Relatives

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; AGED; ARTICLE; CANCER; CANCER INCIDENCE; CANCER RISK; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DENMARK; FEMALE; GENETICS; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; PRIORITY JOURNAL; STOMACH CANCER; SWEDEN;

ADULT; AGED; COMMON VARIABLE IMMUNODEFICIENCY; DENMARK; FEMALE; HUMANS; IGG DEFICIENCY; INCIDENCE; INFANT, NEWBORN; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS; PARENTS; RISK; SEX DISTRIBUTION; SIBLINGS; STOMACH NEOPLASMS; SWEDEN;

EID: 18744411225     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.02004.x     Document Type: Article

References (18)

1. Kinlen L, Webster ADB, Bird AG et al. Prospective study of cancer in patients with hypogammaglobulinemia. Lancet 1985; 1:263-5.
2. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 1987; 7:294-9.
3. Morrell D, Chase CL, Swift M. Cancer and autoimmune disease in families with common variable immune deficiency. General Epidemiol 1986; 3:17-26.
4. Koch C, Andersen V, Faber V, Friis B, Pedersen FK, Platz P. Primære immundefekter i Danmark. Ugeskr Læger 1981; 143:2479-84.
5. Danish National Board of Health. Cancer incidence in Denmark 1996. Copenhagen: Danish National Board of Health, 1999.
6. Centre for Epidemiology, The Swedish Cancer Registry. Cancer incidence in Sweden 1990. Stockholm: National Board of Health and Welfare, 1993.
7. Rothman KJ, Boice JD. Epidemiologic analysis with a programmable calculator. DHHS Publication No. (NIH) 79-1649. Washington, DC: US Government Printing Office, 1979.
8. Filipovich AH, Mathur A, Kamat D, Kersey JH, Shapiro RS. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 1994; 5:91-112.
9. Hermans PE, Diaz-Buxo J, Stobo JD. Idiopathic late-onset immunoglobulin deficiency. Am J Med 1976; 61:221-37.
10. Hermaszewski RA, Webster A. Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications. Q J Med 1993; 86:31-42.
11. Report of an IUIS Scientific Committee. Primary immunodeficiency diseases. Clin Exp Immunol 1999; 118:1-28.
12. Koskinen S. Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol 1996; 16:165-70.
13. Cunningham-Rundles C, Pudifin DJ, Armstrong D, Gordon DA. Selective IgA: Deficiency and neoplasia. Vox Sang 1980; 38:61-7.
14. Hammarström L, Smith C. Genetic approach to common variable immunodeficiency and IgA deficiency. In: Ochs HD, Smith C, Puck JM, eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. New York: Oxford University Press, 1999: 250-62.
15. Shyur S-D, Hill HR. Recent advances in the genetics of primary immunodeficiency syndromes. J Pediatr 1996; 129:8-24.
16. World Health Organization, International Agency for Research on Cancer. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon: IARC, 1997.
17. Bogstedt AK, Nava S, Wadstrom T, Hammarstrom L. Helicobacter pylori infections in IgA deficiency: Lack of role for the secretory immune system. Clin Exp Immunol 1996; 105:202-4.
18. Zullo A, Romiti A, Rinaldi V et al. Gastric pathology in patients with common variable immunodeficiency. Gut 1999; 45:77-81.